• 1. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 2. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 3. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126

Introduction to 2-bromo-4-chlorophenyl chloroformate (CAS No. 1509029-49-5)

2-bromo-4-chlorophenyl chloroformate, identified by the Chemical Abstracts Service Number (CAS No.) 1509029-49-5, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound serves as a crucial intermediate in the synthesis of various biologically active molecules, particularly in the development of novel therapeutic agents. Its unique structural features, comprising both bromo and chloro substituents on a phenyl ring, make it a versatile building block for further chemical modifications.

The bromo and chloro functional groups on the aromatic ring of 2-bromo-4-chlorophenyl chloroformate contribute to its reactivity, enabling it to participate in nucleophilic substitution reactions, cross-coupling reactions, and other transformations essential for drug discovery. The presence of the chloroformate group further enhances its utility as a synthetic precursor, allowing for the introduction of ester functionalities into target molecules. This makes it particularly valuable in medicinal chemistry, where ester derivatives are frequently explored for their pharmacological properties.

In recent years, there has been a surge in research focused on developing new methodologies for the functionalization of aromatic compounds. The 2-bromo-4-chlorophenyl chloroformate molecule has been employed in several innovative synthetic strategies that leverage its reactivity to construct complex scaffolds. For instance, studies have demonstrated its use in palladium-catalyzed cross-coupling reactions, which are pivotal in forming carbon-carbon bonds and creating diverse molecular architectures. These reactions often yield high yields and regioselectivity, making them attractive for industrial applications.

One notable application of 2-bromo-4-chlorophenyl chloroformate is in the synthesis of kinase inhibitors, which are critical in treating cancers and inflammatory diseases. The ability to introduce ester groups via chloroformate chemistry allows researchers to generate analogs with tailored solubility and bioavailability profiles. Additionally, the compound has been utilized in the development of protease inhibitors, where its structural motif plays a key role in binding to enzyme active sites. These findings highlight its importance in modern drug design.

The pharmaceutical industry has also explored the use of 2-bromo-4-chlorophenyl chloroformate in the preparation of vaccine adjuvants. By modifying its structure to include hydrophilic or lipophilic groups, researchers can enhance vaccine efficacy and immunogenicity. This underscores the compound's versatility beyond traditional small-molecule drug development. Furthermore, agrochemical researchers have investigated its potential as a precursor for novel pesticides and herbicides, leveraging its reactivity to create compounds that exhibit improved environmental profiles.

Advances in computational chemistry have further accelerated the utilization of 2-bromo-4-chlorophenyl chloroformate by enabling virtual screening and molecular docking studies. These techniques allow researchers to predict the binding affinities and interactions of this compound with biological targets, streamlining the drug discovery process. The integration of machine learning algorithms has also facilitated the identification of new synthetic pathways for this molecule, reducing experimental trial-and-error and optimizing reaction conditions.

The safety and handling of 2-bromo-4-chlorophenyl chloroformate are critical considerations in industrial and laboratory settings. While it is not classified as a hazardous material under standard regulations, proper precautions must be taken to ensure safe handling due to its reactivity with nucleophiles. Storage conditions should be controlled to prevent degradation or unintended reactions, typically involving cool, dry environments away from incompatible substances.

In conclusion, 2-bromo-4-chlorophenyl chloroformate (CAS No. 1509029-49-5) represents a significant tool in synthetic organic chemistry with broad applications across pharmaceuticals, agrochemicals, and material science. Its unique structural features and reactivity make it indispensable for constructing biologically active molecules. As research continues to evolve, this compound will undoubtedly play an even greater role in advancing chemical innovation and therapeutic development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)